In contrast, CFTR has also been reported to function as a tumor suppressor 33, and downregulation or mutation of CFTR activates proliferation, invasion, migration, and the epithelial–mesenchymal transition in breast cancer and prostate cancer 34, 35, 36. This evidence concerns the gene CFTR and prostate cancer.